Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 25 Oct 2023

Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)

in Hematologic Malignancies

Ga-Young Song
Je-Jung Lee
Joon Ho Moon
Dajung Kim
Min Kyoung Kim
Hyo Jung Kim
Yeung-Chul Mun
Won-Sik Lee
Young Rok Do
Jae Hoon Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1209110

2,671 views

Original Research

Published on 25 Oct 2023

Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies

in Hematologic Malignancies

Philippe Decruyenaere
Edoardo Giuili
Kimberly Verniers
Jasper Anckaert
Katrien De Grove
Malaïka Van der Linden
Dries Deeren
Jo Van Dorpe
Fritz Offner
Jo Vandesompele

Frontiers in Oncology

doi 10.3389/fonc.2023.1221471

5,394 views
3 citations

Original Research

Published on 24 Oct 2023

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling

in Hematologic Malignancies

Kathrin Olschok
Bianca Altenburg
Marcelo A. S. de Toledo
Angela Maurer
Anne Abels
Fabian Beier
Deniz Gezer
Susanne Isfort
Katrin Paeschke
Tim H. Brümmendorf

Frontiers in Oncology

doi 10.3389/fonc.2023.1277453

6,291 views
11 citations

Original Research

Published on 24 Oct 2023

Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China

in Hematologic Malignancies

Jiaxin Liu
Yunfei Hu
Linjun Zhao
Reyizha Nuersulitan
Yanfei Liu
Hui Yu
Yingying Ye
Dedao Wang
Yongjing Tang
Feier Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1264723

3,995 views
2 citations

Case Report

Published on 24 Oct 2023

The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review

in Hematologic Malignancies

Witold Prejzner
Oliwia Piekoś
Karolina Bełdzińska
Alicja Sadowska-Klasa
Ewa Zarzycka
Maria Bieniaszewska
Krzysztof Lewandowski
Jan Maciej Zaucha

Frontiers in Oncology

doi 10.3389/fonc.2023.1228481

6,521 views
5 citations

Addendum

Published on 20 Oct 2023

Addendum: B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: a case report

in Hematologic Malignancies

Sander Eens
Manon Van Hecke
Kasper Favere
Thomas Tousseyn
Pieter-Jan Guns
Tania Roskams
Hein Heidbuchel

Frontiers in Oncology

doi 10.3389/fonc.2023.1267904

11,215 views
1 citation

Review

Published on 20 Oct 2023

Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities

in Hematologic Malignancies

Maya Rosenberg
Maria Poluch
Colin Thomas
Paola Sindaco
Alan Khoo
Pierluigi Porcu

Frontiers in Oncology

doi 10.3389/fonc.2023.1275800

5,710 views
6 citations

Case Report

Published on 20 Oct 2023

Case Report: Treatment of the rare B-cell lymphoblastic lymphoma with scalp lesion using rotation flap

in Hematologic Malignancies

Timothy Kim
Geena Jung
Emery Buckner-Wolfson
Ryan Fatemi
Genesis Liriano
Adit Tal
Yanhua Wang
Oren Tepper
Andrew Kobets

Frontiers in Oncology

doi 10.3389/fonc.2023.1252512

3,109 views
1 citation

Case Report

Published on 18 Oct 2023

Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy

in Hematologic Malignancies

Timothy Woo
Matthew Carter
George Follows
Piers EM. Patten

Frontiers in Oncology

doi 10.3389/fonc.2023.1260003

3,328 views
2 citations

Review

Published on 17 Oct 2023

Checkpoint inhibition in hematologic malignancies

in Hematologic Malignancies

Aaron Tsumura
Daniel Levis
Joseph M. Tuscano

Frontiers in Oncology

doi 10.3389/fonc.2023.1288172

5,371 views
6 citations

Original Research

Published on 16 Oct 2023

Prognostic significance of the systemic immune-inflammation index in patients with extranodal natural killer/T-cell lymphoma

in Hematologic Malignancies

Tao Hai
Wanchun Wu
Kexin Ren
Na Li
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2023.1273504

8,737 views

Review

Published on 16 Oct 2023

SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances

in Hematologic Malignancies

Jingyu Song
Huibo Li
Shengjin Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1269531

4,510 views
3 citations

Original Research

Published on 16 Oct 2023

TP53 Gene 72 Arg/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia

in Hematologic Malignancies

Asma Ounalli
Imen Moumni
Amal Mechaal
Aya Chakroun
Mbarka Barmat
Rim El Elj Rhim
Samia Menif
Ines Safra

Frontiers in Oncology

doi 10.3389/fonc.2023.1272876

3,644 views
7 citations

Brief Research Report

Published on 13 Oct 2023

The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation

in Hematologic Malignancies

Yuyan Shen
Donglin Yang
Rongli Zhang
Xin Chen
Qiaoling Ma
Jialin Wei
Weihua Zhai
Aiming Pang
Yi He
Erlie Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1256043

2,361 views
2 citations

Review

Published on 13 Oct 2023

Germline and somatic drivers in inherited hematologic malignancies

in Hematologic Malignancies

Julian Zoller
Despina Trajanova
Simone Feurstein

Frontiers in Oncology

doi 10.3389/fonc.2023.1205855

4,428 views

Systematic Review

Published on 06 Oct 2023

Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis

in Hematologic Malignancies

Jianzhu Xiong
Kangkang Chen
Wen Huang
Mingang Huang
Feiyan Cao
Yiwen Wang
Qifeng Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1249353

2,691 views
4 citations